Clinical trials: Postprandial
Type I Diabetes
Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm
The aim of this study is to demonstrate the efficacy of an algorithm to anticipate the post prandial glycemic profile in type I diabetic patient.
- Trial name
- EGHYA (NCT05151770)
- Testing
- Measure of glycemia levels and comparison to algorithm predictions
- Where
- 2 sites in France
- Volunteers
- 40 people
- Sponsor
- M-DT1
Glycemic Response
Blood Glucose Response of Processed Starch
The goal of this clinical trial is to determine the postprandial glycemic response of the two starches in humans. Participants will be asked to consume 2 test foods on 2 separate occasions and provide blood glucose samples over…
- Trial name
- NCT06048978
- Testing
- Commercial native starch without processing, Modified starch with extrusion processing
- Where
- Canada
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- INQUIS Clinical Research
Healthy
Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation
The purpose of this study is to evaluate the pharmacokinetics of the new formulation of zolpidem hemitartarate orodispersible tablet 3.5 mg in male and female healthy volunteers.
- Trial name
- NCT02817750
- Testing
- zolpidem hemitartarate tablet 3.5 mg (fasting + post-prandial), zolpidem hemitartarate tablet 3.5 mg (post-prandial + fasting)
- Where
- Brazil
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Biolab Sanus Farmaceutica
Bloating, Gastrointestinal Symptoms
A Clinical Trial to Investigate the Safety and Efficacy of Bloat on Postprandial Bloating and Its Effects Over Time in Healthy Women
The goal of this clinical trial is to investigate the safety and efficacy of Bloat on postprandial bloating in healthy women. The main question it aims to answer is what is the difference in change in bloating from pre-dose…
- Conditions
- Bloating, Gastrointestinal Symptoms, Intestinal Gas
- Trial name
- NCT07370740
- Testing
- Bloat
- Where
- Canada
- Volunteers
- 100 people
- Sponsor
- Arrae
Healthy
A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test Fiber
The objective of this trial is to evaluate the postprandial glucose and insulin responses to replacing digestible carbohydrates with resistant starch type 4 (RS4) in a baked product in healthy men and women.
- Trial name
- NCT03239288
- Testing
- Control digestible carbohydrate, Test resistant starch type 4
- Where
- United States
- Volunteers
- 22 people, healthy volunteers welcome
- Sponsor
- Cargill
Type II Diabetes Mellitus
Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
Primary Objective: To evaluate the ability of lixisenatide to modulate postprandial hyperlipidemia in particular, the effects on plasma changes in triglycerides.
- Trial name
- NCT02274740
- Testing
- LIXISENATIDE AVE0010, metformin
- Volunteers
- 2 people
- Sponsor
- Sanofi
Type 2 Diabetes Mellitus
Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
Primary Objective: To demonstrate significant reduction in postprandial plasma glucose (ΔAUC0:30-4:30h) after a standardized breakfast from baseline to Day 29.
- Trial name
- NCT02200991
- Testing
- LIXISENATIDE AVE0010, Sitagliptin, Insulin glargine HOE901
- Where
- 20 sites in Japan
- Volunteers
- 136 people
- Sponsor
- Sanofi
Healthy
YH4808 Postprandial PK/PD Study in Healthy Subjects
A clinical Study to evaluate the safety and pharmacokinetics/pharmacodynamics(PK/PD) of YH4808 after repeated Oral administration and Postprandial state in healthy volunteers
- Trial name
- NCT01761513
- Testing
- YH4808
- Where
- South Korea
- Volunteers
- 21 people, healthy volunteers welcome
- Sponsor
- Yuhan Corporation
Colorectal Cancer
Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer Patients
Trifluridine and Tipiracil Tablets is a nucleoside anti-metabolic and anti-cancer compound developed by Taiho (Dapeng) Co., Ltd., Japan, for the treatment of advanced colorectal cancer that inoperable resection, and progressed or…
- Trial name
- NCT03974594
- Testing
- Trifluridine and Tipiracil Tablets, TAS-102
- Where
- China
- Volunteers
- 64 people
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatitis B
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects
This study is an open-label, randomized, single dose, crossover study to evaluate the pharmacokinetics, safety and tolerability of DA-2803 in healthy subjects
- Trial name
- NCT04906109
- Testing
- Vemlidy Tab, DA-2803 Tab
- Where
- South Korea
- Volunteers
- 96 people, healthy volunteers welcome
- Sponsor
- Dong-A ST Co., Ltd.
Glycemic Index
Effect of Added Fruit Pomace Fiber, Juice, and Whole Fruit on Postprandial Glycemia
Compare the effects of whole orange, orange juice alone, and orange juice with added orange pomace fiber, and whole apple, apple juice alone, and apple juice with added apple pomace fiber, on 2h glycemic response.
- Trial name
- NCT04182971
- Testing
- Fruit, Fruit juice, Fruit juice plus fiber
- Where
- United States
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- PepsiCo Global R&D
Digestive Health, Gastrointestinal Health
Effects of Microbial Protease Supplementation on Postprandial Plasma Amino Acid Concentrations and Appetite
The primary purpose of this study is to assess the effect of co-ingestion of microbial proteases and whey protein concentrate (WPC) on postprandial plasma amino acid concentrations in healthy adult participants compared to WPC…
- Conditions
- Digestive Health, Gastrointestinal Health, Appetitive Behavior
- Trial name
- NCT05957185
- Testing
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Where
- Canada
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- BIO-CAT, Inc.
Diabetes Mellitus
Evaluation of the Effects of Heating the Vicinity of the Insulin Delivery Site by the Experimental Device
The study is an open-label, randomized, two-period, one-way crossover study using the Meal Tolerance Test (MTT) protocol or the daily life setting protocol. The study consists of two parts.
- Trial name
- NCT02306343
- Testing
- InsuPad
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Insuline Medical Ltd.
Glucose Response, Insulin Response
Glucose and Insulin Responses to Test Foods
In this study, postprandial glucose and insulin responses of different foods will be measured in individuals with varying body weight.
- Trial name
- NCT01671878
- Testing
- Reference Glucose, Test Food 1 (Cereal), Test Food 2 (Biscuit)
- Where
- Canada
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Mondelēz International, Inc.
Glycemic Response
Glin4: Assessment of the Glycemic Responses to Nutritional Products
This study assesses the glycemic responses to nutritional products. During a study visit fasted subjects will consume one serving of the reference product or the test product.
- Trial name
- GLIN4 (NCT06797349)
- Testing
- First Reference product, Second reference product, Third reference product
- Where
- Canada
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Nutricia Research
Diabetes, Diabetes Mellitus, Type 2
Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
This trial is conducted in the United States of America (USA). The aim of this trial is to compare the effect of repaglinide on postprandial lipemia in subjects with type 2 diabetes.
- Trial name
- NCT01605773
- Testing
- repaglinide, glyburide
- Where
- United States
- Volunteers
- 51 people
- Sponsor
- Novo Nordisk A/S
Type 2 Diabetes Mellitus
Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500
The study is to compare meal time glucose control associated with BIOD-531, a rapidly absorbed concentrated insulin to that associated with Humalog Mix 75/25 and Humulin R U-500.
- Trial name
- NCT02212951
- Testing
- BIOD-531, Humalog Mix 75/25, Humulin R U-500
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Biodel
Postbariatric Hypoglycemia
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions
This is a phase 2 crossover, randomized, placebo-controlled, single-blind, repeat dose study in PBH subjects to determine the effect of mizagliflozin on adverse events and postprandial glucose excursions.
- Trial name
- NCT05721729
- Testing
- Mizagliflozin
- Where
- 2 sites in United States
- Volunteers
- 15 people
- Sponsor
- Vogenx, Inc.
Type 2 Diabetes Mellitus
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
This purpose of this study is to compare the effect of exenatide to that of sitagliptin on 2-hour postprandial glucose in subjects with type 2 diabetes mellitus.
- Trial name
- NCT00477581
- Testing
- exenatide, sitagliptin
- Where
- 19 sites in United States
- Volunteers
- 102 people
- Sponsor
- AstraZeneca
Post-prandial Glycemia
Effect of Mulberry Leaf Extract on Glucose Response of a Test Meal
The aim of this study is to test the effects of Mulberry leaf extract on glucose response of a standardized complete meal when taken just before or when mixed with the meal.
- Trial name
- NCT05112133
- Testing
- Mulberry leaf extract, Water
- Where
- Switzerland
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)